{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:25:06Z","timestamp":1787214306261,"version":"build-2736575974"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hunan Provincial Key Laboratory of Tumor Microenvironment responsive Drug Research","award":["2019TP1041"],"award-info":[{"award-number":["2019TP1041"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82404434, 82304420"],"award-info":[{"award-number":["82404434, 82304420"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2024JJ6405, 2024JJ8149, 2023JJ40576"],"award-info":[{"award-number":["2024JJ6405, 2024JJ8149, 2023JJ40576"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"DOI":"10.1007\/s00280-026-04918-5","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:04:59Z","timestamp":1787213099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intensification versus combination: revisiting the past and envisioning the future of LDHA inhibitors"],"prefix":"10.1007","volume":"96","author":[{"given":"Weixi","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxiao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guotao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangping","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"1","key":"4918_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-023-01841-8","volume":"22","author":"SW Yue","year":"2023","unstructured":"Yue SW, Liu HL, Su HF et al (2023) m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism. Mol Cancer 22(1):137. https:\/\/doi.org\/10.1186\/s12943-023-01841-8","journal-title":"Mol Cancer"},{"issue":"1","key":"4918_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1158\/jcr.1925.148","volume":"9","author":"O Warburg","year":"1925","unstructured":"Warburg O (1925) The Metabolism of Carcinoma Cells. J Cancer Res 9(1):148\u2013163. https:\/\/doi.org\/10.1158\/jcr.1925.148","journal-title":"J Cancer Res"},{"issue":"5","key":"4918_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","volume":"5","author":"GN Masoud","year":"2015","unstructured":"Masoud GN, Li W (2015) HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy. Acta Pharm Sin B 5(5):378\u2013389. https:\/\/doi.org\/10.1016\/j.apsb.2015.05.007","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"4918_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41419-026-08494-7","volume":"17","author":"C Yang","year":"2026","unstructured":"Yang C, Yang R, Zheng B, Jiang H, Wang X, Huang W (2026) Lactylation as a metabolic-epigenetic switch in cancer: dual roles in cell death resistance and therapeutic vulnerability. Cell Death Dis 17(1):298. https:\/\/doi.org\/10.1038\/s41419-026-08494-7","journal-title":"Cell Death Dis"},{"key":"4918_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.20517\/cdr.2025.90","volume":"8","author":"C Li","year":"2025","unstructured":"Li C, Liu Z, Kong D, Li Z, Li L (2025) Lactylation: a novel driver of drug resistance in the tumor microenvironment. Cancer Drug Resist 8:39. https:\/\/doi.org\/10.20517\/cdr.2025.90","journal-title":"Cancer Drug Resist"},{"key":"4918_CR6","doi-asserted-by":"publisher","first-page":"1038421","DOI":"10.3389\/fphys.2022.1038421","volume":"13","author":"Y Lin","year":"2022","unstructured":"Lin Y, Wang Y, Li PF (2022) Mutual regulation of lactate dehydrogenase and redox robustness. Front Physiol 13:1038421. https:\/\/doi.org\/10.3389\/fphys.2022.1038421","journal-title":"Front Physiol"},{"issue":"4","key":"4918_CR7","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/cells15040362","volume":"15","author":"S Li","year":"2026","unstructured":"Li S, Gong J, Kang B et al (2026) Targeting Glycolytic Metabolism in Cancer Therapy: Current Approaches and Future Perspectives. Cells 15(4):362. https:\/\/doi.org\/10.3390\/cells15040362","journal-title":"Cells"},{"issue":"1","key":"4918_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13065-023-00991-6","volume":"17","author":"S Damavandi","year":"2023","unstructured":"Damavandi S, Shiri F, Emamjomeh A, Pirhadi S, Beyzaei H (2023) A study of the interaction space of two lactate dehydrogenase isoforms (LDHA and LDHB) and some of their inhibitors using proteochemometrics modeling. BMC Chem 17(1):70. https:\/\/doi.org\/10.1186\/s13065-023-00991-6","journal-title":"BMC Chem"},{"issue":"1","key":"4918_CR9","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.1038\/s41467-022-33299-5","volume":"13","author":"C Diot","year":"2022","unstructured":"Diot C, Garc\u00eda-Gonz\u00e1lez AP, Vieira AF et al (2022) Bacterial diet modulates tamoxifen-induced death via host fatty acid metabolism. Nat Commun 13(1):5595. https:\/\/doi.org\/10.1038\/s41467-022-33299-5","journal-title":"Nat Commun"},{"key":"4918_CR10","doi-asserted-by":"publisher","first-page":"115766","DOI":"10.1016\/j.biopha.2023.115766","volume":"168","author":"Q Wu","year":"2023","unstructured":"Wu Q, Li J, Hao S et al (2023) Caffeic acid phenethyl ester inhibits MDA-MB-231 cell proliferation in inflammatory microenvironment by suppressing glycolysis and lipid metabolism. Biomed Pharmacother 168:115766. https:\/\/doi.org\/10.1016\/j.biopha.2023.115766","journal-title":"Biomed Pharmacother"},{"key":"4918_CR11","doi-asserted-by":"publisher","first-page":"115939","DOI":"10.1016\/j.bcp.2023.115939","volume":"219","author":"L Chen","year":"2024","unstructured":"Chen L, Shi H, Zhang W et al (2024) Carfilzomib suppressed LDHA-mediated metabolic reprogramming by targeting ATF3 in esophageal squamous cell carcinoma. Biochem Pharmacol 219:115939. https:\/\/doi.org\/10.1016\/j.bcp.2023.115939","journal-title":"Biochem Pharmacol"},{"key":"4918_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molimm.2022.12.015","volume":"154","author":"YT Zhang","year":"2023","unstructured":"Zhang YT, Xing ML, Fang HH, Li WD, Wu L, Chen ZP (2023) Effects of lactate on metabolism and differentiation of CD4\u2009+\u2009T cells. Mol Immunol 154:96\u2013107. https:\/\/doi.org\/10.1016\/j.molimm.2022.12.015","journal-title":"Mol Immunol"},{"key":"4918_CR13","doi-asserted-by":"publisher","first-page":"106303","DOI":"10.1016\/j.bioorg.2022.106303","volume":"131","author":"RM Elbagoury","year":"2023","unstructured":"Elbagoury RM, Shenouda MA, Elnakib HE, Wober J, Abadi AH, Ahmed NS (2023) Design, synthesis, and metabolite identification of Tamoxifen esterase-activatable prodrugs. Bioorg Chem 131:106303. https:\/\/doi.org\/10.1016\/j.bioorg.2022.106303","journal-title":"Bioorg Chem"},{"issue":"10","key":"4918_CR14","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3390\/ph16101392","volume":"16","author":"NNE El-Sayed","year":"2023","unstructured":"El-Sayed NNE, Al-Otaibi TM, Barakat A et al (2023) Synthesis and Biological Evaluation of Some New 3-Aryl-2-thioxo-2,3-dihydroquinazolin-4(1H)-ones and 3-Aryl-2-(benzylthio)quinazolin-4(3H)-ones as Antioxidants; COX-2, LDHA, \u03b1-Glucosidase and \u03b1-Amylase Inhibitors; and Anti-Colon Carcinoma and Apoptosis-Inducing Agents. Pharmaceuticals 16(10):1392. https:\/\/doi.org\/10.3390\/ph16101392","journal-title":"Pharmaceuticals"},{"issue":"1","key":"4918_CR15","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1021\/acs.jmedchem.2c01505","volume":"66","author":"N Sun","year":"2023","unstructured":"Sun N, Kabir M, Lee Y et al (2023) Discovery of the First Lactate Dehydrogenase Proteolysis Targeting Chimera Degrader for the Treatment of Pancreatic Cancer. J Med Chem 66(1):596\u2013610. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01505","journal-title":"J Med Chem"},{"key":"4918_CR16","doi-asserted-by":"publisher","first-page":"217527","DOI":"10.1016\/j.canlet.2025.217527","volume":"613","author":"W Yuan","year":"2025","unstructured":"Yuan W, Lu G, Zhao Y et al (2025) Intranuclear TCA and mitochondrial overload: The nascent sprout of tumors metabolism. Cancer Lett 613:217527. https:\/\/doi.org\/10.1016\/j.canlet.2025.217527","journal-title":"Cancer Lett"},{"issue":"12","key":"4918_CR17","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.1002\/cam4.1820","volume":"7","author":"Y Feng","year":"2018","unstructured":"Feng Y, Xiong Y, Qiao T, Li X, Jia L, Han Y (2018) Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy. Cancer Med 7(12):6124\u20136136. https:\/\/doi.org\/10.1002\/cam4.1820","journal-title":"Cancer Med"},{"issue":"12","key":"4918_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41571-022-00686-2","volume":"19","author":"G Claps","year":"2022","unstructured":"Claps G, Faouzi S, Quidville V et al (2022) The multiple roles of LDH in cancer. Nat Rev Clin Oncol 19(12):749\u2013762. https:\/\/doi.org\/10.1038\/s41571-022-00686-2","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"4918_CR19","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3390\/cancers11060750","volume":"11","author":"D Mishra","year":"2019","unstructured":"Mishra D, Banerjee D (2019) Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment. Cancers 11(6):750. https:\/\/doi.org\/10.3390\/cancers11060750","journal-title":"Cancers"},{"issue":"5","key":"4918_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.4155\/fmc-2019-0287","volume":"12","author":"MR Woodford","year":"2020","unstructured":"Woodford MR, Chen VZ, Backe SJ, Bratslavsky G, Mollapour M (2020) Structural and functional regulation of lactate dehydrogenase-A in cancer. Future Med Chem 12(5):439\u2013455. https:\/\/doi.org\/10.4155\/fmc-2019-0287","journal-title":"Future Med Chem"},{"issue":"4","key":"4918_CR21","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/S0006-291X(02)00768-4","volume":"295","author":"MJ Flick","year":"2002","unstructured":"Flick MJ, Konieczny SF (2002) Identification of putative mammalian d-lactate dehydrogenase enzymes. Biochem Biophys Res Commun 295(4):910\u2013916. https:\/\/doi.org\/10.1016\/S0006-291X(02)00768-4","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"4918_CR22","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1093\/jn\/135.7.1619","volume":"135","author":"JB Ewaschuk","year":"2005","unstructured":"Ewaschuk JB, Naylor JM, Zello GA (2005) D-Lactate in Human and Ruminant Metabolism. J Nutr 135(7):1619\u20131625. https:\/\/doi.org\/10.1093\/jn\/135.7.1619","journal-title":"J Nutr"},{"issue":"11","key":"4918_CR23","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1093\/clinchem\/48.11.1938","volume":"48","author":"M Maekawa","year":"2002","unstructured":"Maekawa M, Inomata M, Sasaki MS et al (2002) Electrophoretic variant of a lactate dehydrogenase isoenzyme and selective promoter methylation of the LDHA gene in a human retinoblastoma cell line. Clin Chem 48(11):1938\u20131945","journal-title":"Clin Chem"},{"issue":"5","key":"4918_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/neuonc\/not243","volume":"16","author":"C Chesnelong","year":"2014","unstructured":"Chesnelong C, Chaumeil MM, Blough MD et al (2014) Lactate dehydrogenase A silencing in IDH mutant gliomas. Neuro-Oncol 16(5):686\u2013695. https:\/\/doi.org\/10.1093\/neuonc\/not243","journal-title":"Neuro-Oncol"},{"issue":"4197","key":"4918_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1126\/science.1138367","volume":"189","author":"CL Markert","year":"1975","unstructured":"Markert CL, Shaklee JB, Whitt GS (1975) Evolution of a Gene: Multiple genes for LDH isozymes provide a model of the evolution of gene structure, function and regulation. Science 189(4197):102\u2013114. https:\/\/doi.org\/10.1126\/science.1138367","journal-title":"Science"},{"key":"4918_CR26","doi-asserted-by":"publisher","first-page":"114007","DOI":"10.1016\/j.fct.2023.114007","volume":"180","author":"X Liu","year":"2023","unstructured":"Liu X, Zou X, Zhou Y, Chen R, Peng Y, Qu M (2023) LDHA and LDHB overexpression promoted the Warburg effect in malignantly transformed GES-1 cells induced by N-nitroso compounds. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc 180:114007. https:\/\/doi.org\/10.1016\/j.fct.2023.114007","journal-title":"Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc"},{"issue":"2","key":"4918_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#","volume":"43","author":"JA Read","year":"2001","unstructured":"Read JA, Winter VJ, Eszes CM, Sessions RB, Brady RL (2001) Structural basis for altered activity of M- and H\u2010isozyme forms of human lactate dehydrogenase. Proteins Struct Funct Bioinforma 43(2):175\u2013185. doi: 10.1002\/1097-0134(20010501)43:2<175::aid-prot1029>3.0.co;2-#. PMID: 11276087.","journal-title":"Proteins Struct Funct Bioinforma"},{"issue":"2","key":"4918_CR28","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/0006-291X(88)90455-X","volume":"150","author":"ADB Waldman","year":"1988","unstructured":"Waldman ADB, Hart KW, Clarke AR et al (1988) The use of a genetically engineered tryptophan to identify the movement of a domain of B. stearothermophilus lactate dehydrogenase with the process which limits the steady-state turnover of the enzyme. Biochem Biophys Res Commun 150(2):752\u2013759. https:\/\/doi.org\/10.1016\/0006-291X(88)90455-X","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"4918_CR29","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1107\/S1399004714005422","volume":"70","author":"S Dempster","year":"2014","unstructured":"Dempster S, Harper S, Moses JE, Dreveny I (2014) Structural characterization of the apo form and NADH binary complex of human lactate dehydrogenase. Acta Crystallogr D Biol Crystallogr 70(5):1484\u20131490. https:\/\/doi.org\/10.1107\/S1399004714005422","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"1","key":"4918_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.abb.2010.10.010","volume":"505","author":"K \u015awiderek","year":"2011","unstructured":"\u015awiderek K, Paneth P (2011) Differences and similarities in binding of pyruvate and l-lactate in the active site of M4 and H4 isoforms of human lactate dehydrogenase. Arch Biochem Biophys 505(1):33\u201341. https:\/\/doi.org\/10.1016\/j.abb.2010.10.010","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"4918_CR31","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1021\/cs501704f","volume":"5","author":"K \u015awiderek","year":"2015","unstructured":"\u015awiderek K, Tu\u00f1\u00f3n I, Mart\u00ed S, Moliner V (2015) Protein Conformational Landscapes and Catalysis. Influence of Active Site Conformations in the Reaction Catalyzed by L-Lactate Dehydrogenase. ACS Catal 5(2):1172\u20131185. https:\/\/doi.org\/10.1021\/cs501704f","journal-title":"ACS Catal"},{"issue":"6098","key":"4918_CR32","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/324699a0","volume":"324","author":"AR Clarke","year":"1986","unstructured":"Clarke AR, Wigley DB, Chia WN, Barstow D, Atkinson T, Holbrook JJ (1986) Site-directed mutagenesis reveals role of mobile arginine residue in lactate dehydrogenase catalysis. Nature 324(6098):699\u2013702. https:\/\/doi.org\/10.1038\/324699a0","journal-title":"Nature"},{"issue":"10","key":"4918_CR33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/cac2.12080","volume":"40","author":"H Yu","year":"2020","unstructured":"Yu H, Yin Y, Yi Y et al (2020) Targeting lactate dehydrogenase A (LDHA) exerts antileukemic effects on T-cell acute lymphoblastic leukemia. Cancer Commun 40(10):501\u2013517. https:\/\/doi.org\/10.1002\/cac2.12080","journal-title":"Cancer Commun"},{"key":"4918_CR34","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.biopha.2016.04.029","volume":"81","author":"S Gao","year":"2016","unstructured":"Gao S, Tu DN, Li H et al (2016) Pharmacological or genetic inhibition of LDHA reverses tumor progression of pediatric osteosarcoma. Biomed Pharmacother 81:388\u2013393. https:\/\/doi.org\/10.1016\/j.biopha.2016.04.029","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"4918_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine ZE, Schug ZT, Salvino JM, Dang CV (2022) Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov 21(2):141\u2013162. https:\/\/doi.org\/10.1038\/s41573-021-00339-6","journal-title":"Nat Rev Drug Discov"},{"key":"4918_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.semcancer.2023.12.001","volume":"98","author":"A Hasan","year":"2024","unstructured":"Hasan A, Khan NA, Uddin S, Khan AQ, Steinhoff M (2024) Deregulated transcription factors in the emerging cancer hallmarks. Semin Cancer Biol 98:31\u201350. https:\/\/doi.org\/10.1016\/j.semcancer.2023.12.001","journal-title":"Semin Cancer Biol"},{"key":"4918_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.semcancer.2024.02.002","volume":"99","author":"S Bournaka","year":"2024","unstructured":"Bournaka S, Badra-Fajardo N, Arbi M, Taraviras S, Lygerou Z (2024) The cell cycle revisited: DNA replication past S phase preserves genome integrity. Semin Cancer Biol 99:45\u201355. https:\/\/doi.org\/10.1016\/j.semcancer.2024.02.002","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"4918_CR38","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1172\/JCI69741","volume":"123","author":"JR Doherty","year":"2013","unstructured":"Doherty JR, Cleveland JL (2013) Targeting lactate metabolism for cancer therapeutics. J Clin Invest 123(9):3685\u20133692. https:\/\/doi.org\/10.1172\/JCI69741","journal-title":"J Clin Invest"},{"issue":"7678","key":"4918_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature24057","volume":"551","author":"S Hui","year":"2017","unstructured":"Hui S, Ghergurovich JM, Morscher RJ et al (2017) Glucose feeds the TCA cycle via circulating lactate. Nature 551(7678):115\u2013118. https:\/\/doi.org\/10.1038\/nature24057","journal-title":"Nature"},{"key":"4918_CR40","doi-asserted-by":"publisher","first-page":"100903","DOI":"10.1016\/j.neo.2023.100903","volume":"41","author":"ASA Carreira","year":"2023","unstructured":"Carreira ASA, Ravera S, Zucal C et al (2023) Mitochondrial rewiring drives metabolic adaptation to NAD(H) shortage in triple negative breast cancer cells. Neoplasia 41:100903. https:\/\/doi.org\/10.1016\/j.neo.2023.100903","journal-title":"Neoplasia"},{"issue":"4","key":"4918_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/brainsci8040056","volume":"8","author":"CJ Valvona","year":"2018","unstructured":"Valvona CJ, Fillmore HL (2018) Oxamate, but Not Selective Targeting of LDH-A, Inhibits Medulloblastoma Cell Glycolysis, Growth and Motility. Brain Sci 8(4):56. https:\/\/doi.org\/10.3390\/brainsci8040056","journal-title":"Brain Sci"},{"key":"4918_CR42","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.biopha.2017.09.090","volume":"95","author":"AE El-Sisi","year":"2017","unstructured":"El-Sisi AE, Sokar SS, Abu-Risha SE, El-Mahrouk SR (2017) Oxamate potentiates taxol chemotherapeutic efficacy in experimentally-induced solid ehrlich carcinoma (SEC) in mice. Biomed Pharmacother Biomedecine Pharmacother 95:1565\u20131573. https:\/\/doi.org\/10.1016\/j.biopha.2017.09.090","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"issue":"8","key":"4918_CR43","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1080\/19420862.2018.1518948","volume":"10","author":"S Lin","year":"2018","unstructured":"Lin S, Huang G, Cheng L et al (2018) Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1\/PD-1 targeted immunotherapy. mAbs 10(8):1301\u20131311. https:\/\/doi.org\/10.1080\/19420862.2018.1518948","journal-title":"mAbs"},{"issue":"6","key":"4918_CR44","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.3892\/or.2013.2735","volume":"30","author":"X Zhai","year":"2013","unstructured":"Zhai X, Yang Y, Wan J, Zhu R, Wu Y (2013) Inhibition of LDH-A by oxamate induces G2\/M arrest, apoptosis and increases radiosensitivity in nasopharyngeal carcinoma cells. Oncol Rep 30(6):2983\u20132991. https:\/\/doi.org\/10.3892\/or.2013.2735","journal-title":"Oncol Rep"},{"issue":"5","key":"4918_CR45","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.3892\/ijo.2013.2080","volume":"43","author":"X Li","year":"2013","unstructured":"Li X, Lu W, Hu Y et al (2013) Effective inhibition of nasopharyngeal carcinoma in vitro and in vivo by targeting glycolysis with oxamate. Int J Oncol 43(5):1710\u20131718. https:\/\/doi.org\/10.3892\/ijo.2013.2080","journal-title":"Int J Oncol"},{"key":"4918_CR46","doi-asserted-by":"publisher","unstructured":"A C, J R, R T et al (2004) Identification and activity of a series of azole-based compounds with lactate dehydrogenase-directed anti-malarial activity. J Biol Chem 279(30). https:\/\/doi.org\/10.1074\/jbc.M402433200","DOI":"10.1074\/jbc.M402433200"},{"issue":"16","key":"4918_CR47","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1016\/j.bmcl.2014.06.076","volume":"24","author":"PS Dragovich","year":"2014","unstructured":"Dragovich PS, Fauber BP, Boggs J et al (2014) Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase. Bioorg Med Chem Lett 24(16):3764\u20133771. https:\/\/doi.org\/10.1016\/j.bmcl.2014.06.076","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"4918_CR48","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/nchembio.2143","volume":"12","author":"A Boudreau","year":"2016","unstructured":"Boudreau A, Purkey HE, Hitz A et al (2016) Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition. Nat Chem Biol 12(10):779\u2013786. https:\/\/doi.org\/10.1038\/nchembio.2143","journal-title":"Nat Chem Biol"},{"issue":"9","key":"4918_CR49","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1111\/cas.15468","volume":"113","author":"M Du","year":"2022","unstructured":"Du M, Yu T, Zhan Q et al (2022) Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation. Cancer Sci 113(9):2974\u20132985. https:\/\/doi.org\/10.1111\/cas.15468","journal-title":"Cancer Sci"},{"issue":"1","key":"4918_CR50","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1038\/s41598-019-40617-3","volume":"9","author":"EY Kim","year":"2019","unstructured":"Kim EY, Chung TW, Han CW et al (2019) A Novel Lactate Dehydrogenase Inhibitor, 1-(Phenylseleno)-4-(Trifluoromethyl) Benzene, Suppresses Tumor Growth through Apoptotic Cell Death. Sci Rep 9(1):3969. https:\/\/doi.org\/10.1038\/s41598-019-40617-3","journal-title":"Sci Rep"},{"issue":"1","key":"4918_CR51","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3109\/13880209.2013.832776","volume":"52","author":"H Keshmiri-Neghab","year":"2014","unstructured":"Keshmiri-Neghab H, Goliaei B (2014) Therapeutic potential of gossypol: An overview. Pharm Biol 52(1):124\u2013128. https:\/\/doi.org\/10.3109\/13880209.2013.832776","journal-title":"Pharm Biol"},{"issue":"1","key":"4918_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13058-017-0818-5","volume":"19","author":"J Xiong","year":"2017","unstructured":"Xiong J, Li J, Yang Q, Wang J, Su T, Zhou S (2017) Gossypol has anti-cancer effects by dual-targeting MDM2 and VEGF in human breast cancer. Breast Cancer Res 19(1):27. https:\/\/doi.org\/10.1186\/s13058-017-0818-5","journal-title":"Breast Cancer Res"},{"issue":"1","key":"4918_CR53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0006-2952(01)00636-0","volume":"62","author":"Y Yu","year":"2001","unstructured":"Yu Y, Deck JA, Hunsaker LA et al (2001) Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C411Abbreviations: LDH, lactate dehydrogenase; and LDH-A4, -B4, and -C4, human lactate dehydrogenases A4, B4, and C4. Biochem Pharmacol 62(1):81\u201389. https:\/\/doi.org\/10.1016\/S0006-2952(01)00636-0","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"4918_CR54","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1021\/jm201734r","volume":"55","author":"RA Ward","year":"2012","unstructured":"Ward RA, Brassington C, Breeze AL et al (2012) Design and Synthesis of Novel Lactate Dehydrogenase A Inhibitors by Fragment-Based Lead Generation. J Med Chem 55(7):3285\u20133306. https:\/\/doi.org\/10.1021\/jm201734r","journal-title":"J Med Chem"},{"issue":"5","key":"4918_CR55","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1073\/pnas.0914433107","volume":"107","author":"A Le","year":"2010","unstructured":"Le A, Cooper CR, Gouw AM et al (2010) Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci 107(5):2037\u20132042. https:\/\/doi.org\/10.1073\/pnas.0914433107","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"4918_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2049-3002-1-19","volume":"1","author":"J Billiard","year":"2013","unstructured":"Billiard J, Dennison JB, Briand J et al (2013) Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells. Cancer Metab 1(1):19. https:\/\/doi.org\/10.1186\/2049-3002-1-19","journal-title":"Cancer Metab"},{"key":"4918_CR57","doi-asserted-by":"publisher","first-page":"106127","DOI":"10.1016\/j.bioorg.2022.106127","volume":"129","author":"A Alejo-Armijo","year":"2022","unstructured":"Alejo-Armijo A, Cuadrado C, Altarejos J et al (2022) Lactate dehydrogenase A inhibitors with a 2,8-dioxabicyclo[3.3.1]nonane scaffold: A contribution to molecular therapies for primary hyperoxalurias. Bioorg Chem 129:106127. https:\/\/doi.org\/10.1016\/j.bioorg.2022.106127","journal-title":"Bioorg Chem"},{"issue":"1","key":"4918_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23(1):3\u201325. https:\/\/doi.org\/10.1016\/S0169-409X(96)00423-1","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"4918_CR59","doi-asserted-by":"publisher","first-page":"582","DOI":"10.7326\/0003-4819-91-4-582","volume":"91","author":"MURDOCHJK KEYSTONE JS","year":"1979","unstructured":"KEYSTONE JS MURDOCHJK (1979) Drugs Five Years Later. Ann Intern Med 91(4):582\u2013586. https:\/\/doi.org\/10.7326\/0003-4819-91-4-582","journal-title":"Ann Intern Med"},{"issue":"2","key":"4918_CR60","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0006-291X(80)90349-6","volume":"92","author":"JP Laclette","year":"1980","unstructured":"Laclette JP, Guerra G, Zetina C (1980) Inhibition of tubulin polymerization by Mebendazole. Biochem Biophys Res Commun 92(2):417\u2013423. https:\/\/doi.org\/10.1016\/0006-291X(80)90349-6","journal-title":"Biochem Biophys Res Commun"},{"key":"4918_CR61","doi-asserted-by":"publisher","unstructured":"Daniel JP, Mesquita FP, Da Silva EL et al (2022) Anticancer potential of mebendazole against chronic myeloid leukemia: in silico and in vitro studies revealed new insights about the mechanism of action. Front Pharmacol 13. https:\/\/doi.org\/10.3389\/fphar.2022.952250","DOI":"10.3389\/fphar.2022.952250"},{"key":"4918_CR62","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cbi.2018.07.026","volume":"293","author":"V Kralova","year":"2018","unstructured":"Kralova V, Hanu\u0161ov\u00e1 V, Caltov\u00e1 K et al (2018) Flubendazole and mebendazole impair migration and epithelial to mesenchymal transition in oral cell lines. Chem Biol Interact 293:124\u2013132. https:\/\/doi.org\/10.1016\/j.cbi.2018.07.026","journal-title":"Chem Biol Interact"},{"issue":"42","key":"4918_CR63","doi-asserted-by":"publisher","first-page":"68571","DOI":"10.18632\/oncotarget.11851","volume":"7","author":"T Williamson","year":"2016","unstructured":"Williamson T, Bai RY, Staedtke V, Huso D, Riggins GJ (2016) Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model. Oncotarget 7(42):68571\u201368584. https:\/\/doi.org\/10.18632\/oncotarget.11851","journal-title":"Oncotarget"},{"issue":"3","key":"4918_CR64","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1530\/ERC-19-0341","volume":"27","author":"T Williamson","year":"2020","unstructured":"Williamson T, Mendes TB, Joe N, Cerutti JM, Riggins GJ (2020) Mebendazole inhibits tumor growth and prevents lung metastasis in models of advanced thyroid cancer. Endocr Relat Cancer 27(3):123\u2013136. https:\/\/doi.org\/10.1530\/ERC-19-0341","journal-title":"Endocr Relat Cancer"},{"key":"4918_CR65","doi-asserted-by":"publisher","first-page":"101449","DOI":"10.1016\/j.eclinm.2022.101449","volume":"49","author":"VM Patil","year":"2022","unstructured":"Patil VM, Menon N, Chatterjee A et al (2022) Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial. eClinicalMedicine 49:101449. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101449","journal-title":"eClinicalMedicine"},{"issue":"17","key":"4918_CR66","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/cancers14174196","volume":"14","author":"Q Li","year":"2022","unstructured":"Li Q, Demir S, Del R\u00edo-\u00c1lvarez \u00c1 et al (2022) Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma. Cancers 14(17):17. https:\/\/doi.org\/10.3390\/cancers14174196","journal-title":"Cancers"},{"issue":"13","key":"4918_CR67","first-page":"1201","volume":"1","author":"Jichiro Sasaki","year":"2002","unstructured":"Sasaki Jichiro, Ramesh R, Chada S, Gomyo Y, Roth JA, Mukhopadhyay T (2002) The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells. Mol Cancer Ther 1(13):1201\u20131209","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"4918_CR68","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/CAD.0b013e32835a43f1","volume":"24","author":"NA Doudican","year":"2013","unstructured":"Doudican NA, Byron SA, Pollock PM, Orlow SJ (2013) XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts. Anticancer Drugs 24(2):181. https:\/\/doi.org\/10.1097\/CAD.0b013e32835a43f1","journal-title":"Anticancer Drugs"},{"key":"4918_CR69","doi-asserted-by":"publisher","first-page":"116630","DOI":"10.1016\/j.taap.2023.116630","volume":"475","author":"EL Da Silva","year":"2023","unstructured":"Da Silva EL, Mesquita FP, Arag\u00e3o DR et al (2023) Mebendazole targets essential proteins in glucose metabolism leading gastric cancer cells to death. Toxicol Appl Pharmacol 475:116630. https:\/\/doi.org\/10.1016\/j.taap.2023.116630","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"4918_CR70","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1021\/jm101007q","volume":"54","author":"C Granchi","year":"2011","unstructured":"Granchi C, Roy S, Giacomelli C et al (2011) Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells. J Med Chem 54(6):1599\u20131612. https:\/\/doi.org\/10.1021\/jm101007q","journal-title":"J Med Chem"},{"issue":"24","key":"4918_CR71","doi-asserted-by":"publisher","first-page":"7331","DOI":"10.1016\/j.bmcl.2011.10.031","volume":"21","author":"C Granchi","year":"2011","unstructured":"Granchi C, Roy S, Mottinelli M et al (2011) Synthesis of sulfonamide-containing N-hydroxyindole-2-carboxylates as inhibitors of human lactate dehydrogenase-isoform 5. Bioorg Med Chem Lett 21(24):7331\u20137336. https:\/\/doi.org\/10.1016\/j.bmcl.2011.10.031","journal-title":"Bioorg Med Chem Lett"},{"issue":"17","key":"4918_CR72","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1002\/cbic.201300562","volume":"14","author":"EC Calvaresi","year":"2013","unstructured":"Calvaresi EC, Granchi C, Tuccinardi T et al (2013) Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitor. Chembiochem Eur J Chem Biol 14(17):2263\u20132267. https:\/\/doi.org\/10.1002\/cbic.201300562","journal-title":"Chembiochem Eur J Chem Biol"},{"issue":"12","key":"4918_CR73","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1080\/15257770.2022.2031215","volume":"41","author":"M Franczak","year":"2022","unstructured":"Franczak M, Kutryb-Zajac B, El Hassouni B et al (2022) The effect of lactate dehydrogenase-A inhibition on intracellular nucleotides and mitochondrial respiration in pancreatic cancer cells. Nucleosides Nucleotides Nucleic Acids 41(12):1375\u20131385. https:\/\/doi.org\/10.1080\/15257770.2022.2031215","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"1","key":"4918_CR74","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1038\/s41598-019-38854-7","volume":"9","author":"F Jafary","year":"2019","unstructured":"Jafary F, Ganjalikhany MR, Moradi A, Hemati M, Jafari S (2019) Novel Peptide Inhibitors for Lactate Dehydrogenase A (LDHA): A Survey to Inhibit LDHA Activity via Disruption of Protein-Protein Interaction. Sci Rep 9(1):4686. https:\/\/doi.org\/10.1038\/s41598-019-38854-7","journal-title":"Sci Rep"},{"issue":"8","key":"4918_CR75","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41594-021-00633-2","volume":"28","author":"MR Woodford","year":"2021","unstructured":"Woodford MR, Baker-Williams AJ, Sager RA et al (2021) The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effect. Nat Struct Mol Biol 28(8):662\u2013670. https:\/\/doi.org\/10.1038\/s41594-021-00633-2","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"4918_CR76","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3390\/molecules25051096","volume":"25","author":"AEGE Amr","year":"2020","unstructured":"Amr AEGE, Mageid REA, El-Naggar M, Naglah AM, Nossier ES, Elsayed EA (2020) Chiral Pyridine-3,5-bis- (L-phenylalaninyl-L-leucinyl) Schiff Base Peptides as Potential Anticancer Agents: Design, Synthesis, and Molecular Docking Studies Targeting Lactate Dehydrogenase-A. Mol Basel Switz 25(5):1096. https:\/\/doi.org\/10.3390\/molecules25051096","journal-title":"Mol Basel Switz"},{"issue":"1","key":"4918_CR77","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1021\/acs.jmedchem.2c01505","volume":"66","author":"N Sun","year":"2023","unstructured":"Sun N, Kabir M, Lee Y et al (2023) Discovery of the First Lactate Dehydrogenase Proteolysis Targeting Chimera Degrader for the Treatment of Pancreatic Cancer. J Med Chem 66(1):596\u2013610. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01505","journal-title":"J Med Chem"},{"key":"4918_CR78","doi-asserted-by":"publisher","unstructured":"Petalcorin MF, Petalcorin MIR (2025) AI-Guided Discovery of LDHA Inhibitors Targeting Cancer Metabolism Using Machine Learning and Generative Chemistry: An End-to-End Drug Discovery Pipeline. Biochemistry. Preprint posted online May 16. https:\/\/doi.org\/10.1101\/2025.05.13.653702","DOI":"10.1101\/2025.05.13.653702"},{"issue":"10","key":"4918_CR79","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s41590-025-02280-x","volume":"26","author":"J Sun","year":"2025","unstructured":"Sun J, Yang J, Tao J et al (2025) Delaying pyroptosis with an AI-screened gasdermin D pore blocker mitigates inflammatory response. Nat Immunol 26(10):1660\u20131672. https:\/\/doi.org\/10.1038\/s41590-025-02280-x","journal-title":"Nat Immunol"},{"issue":"22","key":"4918_CR80","doi-asserted-by":"publisher","first-page":"13034","DOI":"10.1021\/acsomega.0c00715","volume":"5","author":"A Friberg","year":"2020","unstructured":"Friberg A, Rehwinkel H, Nguyen D et al (2020) Structural Evidence for Isoform-Selective Allosteric Inhibition of Lactate Dehydrogenase A. ACS Omega 5(22):13034\u201313041. https:\/\/doi.org\/10.1021\/acsomega.0c00715","journal-title":"ACS Omega"},{"issue":"1","key":"4918_CR81","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12964-025-02337-2","volume":"23","author":"J Ling","year":"2025","unstructured":"Ling J, Zhang J, Wang B, FengSong J, Li T, Chen J (2025) Artificial intelligence-driven discovery of YH395A: A novel TGF\u03b2R1 inhibitor with potent anti-tumor activity against triple-negative breast cancer. Cell Commun Signal CCS 23(1):326. https:\/\/doi.org\/10.1186\/s12964-025-02337-2","journal-title":"Cell Commun Signal CCS"},{"issue":"1","key":"4918_CR82","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41587-024-02143-0","volume":"43","author":"F Ren","year":"2025","unstructured":"Ren F, Aliper A, Chen J et al (2025) A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models. Nat Biotechnol 43(1):63\u201375. https:\/\/doi.org\/10.1038\/s41587-024-02143-0","journal-title":"Nat Biotechnol"},{"key":"4918_CR83","doi-asserted-by":"publisher","first-page":"116598","DOI":"10.1016\/j.ejmech.2024.116598","volume":"275","author":"H Sharma","year":"2024","unstructured":"Sharma H, Mondal S, Urquiza U et al (2024) Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer. Eur J Med Chem 275:116598. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116598","journal-title":"Eur J Med Chem"},{"key":"4918_CR84","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.semcancer.2022.11.007","volume":"87","author":"D Sharma","year":"2022","unstructured":"Sharma D, Singh M, Rani R (2022) Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics. Semin Cancer Biol 87:184\u2013195. https:\/\/doi.org\/10.1016\/j.semcancer.2022.11.007","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"4918_CR85","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-020-00354-w","volume":"6","author":"LE Navas","year":"2021","unstructured":"Navas LE, Carnero A (2021) NAD+ metabolism, stemness, the immune response, and cancer. Signal Transduct Target Ther 6(1):2. https:\/\/doi.org\/10.1038\/s41392-020-00354-w","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"4918_CR86","doi-asserted-by":"publisher","first-page":"590","DOI":"10.7150\/jca.86283","volume":"15","author":"C Cakici","year":"2024","unstructured":"Cakici C, Daylan B, Unluer RS et al (2024) LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer. J Cancer 15(3):590\u2013602. https:\/\/doi.org\/10.7150\/jca.86283","journal-title":"J Cancer"},{"issue":"10421","key":"4918_CR87","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(23)02405-4","volume":"403","author":"A Oaknin","year":"2024","unstructured":"Oaknin A, Gladieff L, Mart\u00ednez-Garc\u00eda J et al (2024) Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial. Lancet Lond Engl 403(10421):31\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(23)02405-4","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"4918_CR88","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1038\/s41467-024-47002-3","volume":"15","author":"E Dumas","year":"2024","unstructured":"Dumas E, Grandal Rejo B, Gougis P et al (2024) Concomitant medication, comorbidity and survival in patients with breast cancer. Nat Commun 15(1):2966. https:\/\/doi.org\/10.1038\/s41467-024-47002-3","journal-title":"Nat Commun"},{"issue":"28","key":"4918_CR89","doi-asserted-by":"publisher","first-page":"31625","DOI":"10.1021\/acsami.2c05841","volume":"14","author":"L Hu","year":"2022","unstructured":"Hu L, Huang S, Chen G et al (2022) Nanodrugs Incorporating LDHA siRNA Inhibit M2-like Polarization of TAMs and Amplify Autophagy to Assist Oxaliplatin Chemotherapy against Colorectal Cancer. ACS Appl Mater Interfaces 14(28):31625\u201331633. https:\/\/doi.org\/10.1021\/acsami.2c05841","journal-title":"ACS Appl Mater Interfaces"},{"issue":"13","key":"4918_CR90","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1158\/0008-5472.CAN-11-0127","volume":"71","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, Liu H, Liu Z et al (2011) Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. Cancer Res 71(13):4585\u20134597. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-0127","journal-title":"Cancer Res"},{"issue":"4","key":"4918_CR91","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/cbin.11476","volume":"45","author":"G Li","year":"2021","unstructured":"Li G, Li Y, Wang DY (2021) Overexpression of miR-329-3p sensitizes osteosarcoma cells to cisplatin through suppression of glucose metabolism by targeting LDHA. Cell Biol Int 45(4):766\u2013774. https:\/\/doi.org\/10.1002\/cbin.11476","journal-title":"Cell Biol Int"},{"issue":"1","key":"4918_CR92","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/bjc.2013.681","volume":"110","author":"M Maftouh","year":"2014","unstructured":"Maftouh M, Avan A, Sciarrillo R et al (2014) Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia. Br J Cancer 110(1):172\u2013182. https:\/\/doi.org\/10.1038\/bjc.2013.681","journal-title":"Br J Cancer"},{"issue":"10","key":"4918_CR93","first-page":"4661","volume":"13","author":"CY Wang","year":"2023","unstructured":"Wang CY, Xuan DTM, Ye PH et al (2023) Synergistic suppressive effects on triple-negative breast cancer by the combination of JTC-801 and sodium oxamate. Am J Cancer Res 13(10):4661\u20134677","journal-title":"Am J Cancer Res"},{"issue":"1","key":"4918_CR94","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3892\/or.2019.7171","volume":"42","author":"H Muramatsu","year":"2019","unstructured":"Muramatsu H, Sumitomo M, Morinaga S et al (2019) Targeting lactate dehydrogenase\u2013A promotes docetaxel\u2013induced cytotoxicity predominantly in castration\u2013resistant prostate cancer cells. Oncol Rep 42(1):224\u2013230. https:\/\/doi.org\/10.3892\/or.2019.7171","journal-title":"Oncol Rep"},{"key":"4918_CR95","doi-asserted-by":"publisher","first-page":"116798","DOI":"10.1016\/j.taap.2023.116798","volume":"482","author":"Y Liu","year":"2024","unstructured":"Liu Y, Yue J, Ren Z et al (2024) Vitamin C enhances the sensitivity of osteosarcoma to arsenic trioxide via inhibiting aerobic glycolysis. Toxicol Appl Pharmacol 482:116798. https:\/\/doi.org\/10.1016\/j.taap.2023.116798","journal-title":"Toxicol Appl Pharmacol"},{"key":"4918_CR96","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1476-4598-9-33","volume":"9","author":"M Zhou","year":"2010","unstructured":"Zhou M, Zhao Y, Ding Y et al (2010) Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Mol Cancer 9:33. https:\/\/doi.org\/10.1186\/1476-4598-9-33","journal-title":"Mol Cancer"},{"issue":"24","key":"4918_CR97","doi-asserted-by":"publisher","first-page":"6239","DOI":"10.3390\/ijms20246239","volume":"20","author":"YJ Liu","year":"2019","unstructured":"Liu YJ, Fan XY, Wang AD et al (2019) LDHA Suppression Altering Metabolism Inhibits Tumor Progress by an Organic Arsenical. Int J Mol Sci 20(24):6239. https:\/\/doi.org\/10.3390\/ijms20246239","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4918_CR98","first-page":"4661","volume":"13","author":"CY Wang","year":"2023","unstructured":"Wang CY, Xuan DTM, Ye PH et al (2023) Synergistic suppressive effects on triple-negative breast cancer by the combination of JTC-801 and sodium oxamate. Am J Cancer Res 13(10):4661\u20134677","journal-title":"Am J Cancer Res"},{"key":"4918_CR99","doi-asserted-by":"publisher","first-page":"121827","DOI":"10.1016\/j.lfs.2023.121827","volume":"328","author":"S Hwang","year":"2023","unstructured":"Hwang S, Park S, Kim JH et al (2023) Targeting HMG-CoA synthase 2 suppresses tamoxifen-resistant breast cancer growth by augmenting mitochondrial oxidative stress-mediated cell death. Life Sci 328:121827. https:\/\/doi.org\/10.1016\/j.lfs.2023.121827","journal-title":"Life Sci"},{"key":"4918_CR100","doi-asserted-by":"publisher","first-page":"926437","DOI":"10.3389\/fonc.2022.926437","volume":"12","author":"P Malvi","year":"2022","unstructured":"Malvi P, Rawat V, Gupta R, Wajapeyee N (2022) Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor\u2013resistant pancreatic ductal adenocarcinoma. Front Oncol 12:926437. https:\/\/doi.org\/10.3389\/fonc.2022.926437","journal-title":"Front Oncol"},{"issue":"21","key":"4918_CR101","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1158\/0008-5472.CAN-20-3242","volume":"81","author":"KW Evans","year":"2021","unstructured":"Evans KW, Yuca E, Scott SS et al (2021) Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer. Cancer Res 81(21):5572\u20135581. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-3242","journal-title":"Cancer Res"},{"issue":"2","key":"4918_CR102","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1158\/0008-5472.CAN-23-0184","volume":"84","author":"S Ahn","year":"2024","unstructured":"Ahn S, Park JH, Grimm SL et al (2024) Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer. Cancer Res 84(2):291\u2013304. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0184","journal-title":"Cancer Res"},{"key":"4918_CR103","doi-asserted-by":"publisher","first-page":"103637","DOI":"10.1016\/j.redox.2025.103637","volume":"83","author":"C Uslu","year":"2025","unstructured":"Uslu C, Kapan E, Lyakhovich A (2025) OXPHOS inhibition overcomes chemoresistance in triple negative breast cancer. Redox Biol 83:103637. https:\/\/doi.org\/10.1016\/j.redox.2025.103637","journal-title":"Redox Biol"},{"issue":"2","key":"4918_CR104","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41589-025-01978-1","volume":"22","author":"NL Tran","year":"2026","unstructured":"Tran NL, Jiang J, Ma M et al (2026) ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDAC. Nat Chem Biol 22(2):260\u2013273. https:\/\/doi.org\/10.1038\/s41589-025-01978-1","journal-title":"Nat Chem Biol"},{"issue":"5","key":"4918_CR105","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ccell.2024.03.005","volume":"42","author":"N Niu","year":"2024","unstructured":"Niu N, Shen X, Wang Z et al (2024) Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer. Cancer Cell 42(5):869\u2013884e9. https:\/\/doi.org\/10.1016\/j.ccell.2024.03.005","journal-title":"Cancer Cell"},{"issue":"1","key":"4918_CR106","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.1038\/s41467-024-51214-y","volume":"15","author":"M Wu","year":"2024","unstructured":"Wu M, Wang T, Ji N et al (2024) Multi-omics and pharmacological characterization of patient-derived glioma cell lines. Nat Commun 15(1):6740. https:\/\/doi.org\/10.1038\/s41467-024-51214-y","journal-title":"Nat Commun"},{"issue":"1","key":"4918_CR107","doi-asserted-by":"publisher","first-page":"e11351","DOI":"10.1002\/adma.202511351","volume":"38","author":"X Han","year":"2026","unstructured":"Han X, Feng F, Wang Z et al (2026) Preventing Glioblastoma Relapse by Igniting Innate Immunity through Mitochondrial Stress in the Surgical Cavity. Adv Mater 38(1):e11351. https:\/\/doi.org\/10.1002\/adma.202511351","journal-title":"Adv Mater"},{"issue":"13","key":"4918_CR108","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-22-3059","volume":"83","author":"Z Lin","year":"2023","unstructured":"Lin Z, Li J, Zhang J et al (2023) Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer. Cancer Res 83(13):2187\u20132207. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-3059","journal-title":"Cancer Res"},{"issue":"7953","key":"4918_CR109","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41586-023-05793-3","volume":"615","author":"M Han","year":"2023","unstructured":"Han M, Bushong EA, Segawa M et al (2023) Spatial mapping of mitochondrial networks and bioenergetics in lung cancer. Nature 615(7953):712\u2013719. https:\/\/doi.org\/10.1038\/s41586-023-05793-3","journal-title":"Nature"},{"issue":"25","key":"4918_CR110","doi-asserted-by":"publisher","first-page":"e2501017","DOI":"10.1002\/advs.202501017","volume":"12","author":"Y Tong","year":"2025","unstructured":"Tong Y, Wang Z, Wang Y et al (2025) The E3 Ubiquitin Ligase ARIH1 Facilitates Colorectal Cancer Progression by Promoting Oxidative Phosphorylation via the Mitochondrial Translocation of K63-Linked Ubiquitinated PHB1. Adv Sci 12(25):e2501017. https:\/\/doi.org\/10.1002\/advs.202501017","journal-title":"Adv Sci"},{"issue":"1","key":"4918_CR111","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.1038\/s41467-024-49221-0","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Duan S, Wang Y et al (2024) MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration. Nat Commun 15(1):4969. https:\/\/doi.org\/10.1038\/s41467-024-49221-0","journal-title":"Nat Commun"},{"issue":"11","key":"4918_CR112","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.3390\/cancers17111793","volume":"17","author":"MA Khajah","year":"2025","unstructured":"Khajah MA, Khushaish S, Luqmani Y (2025) Lactate Is a Major Promotor of Breast Cancer Cell Aggressiveness. Cancers 17(11):1793. https:\/\/doi.org\/10.3390\/cancers17111793","journal-title":"Cancers"},{"issue":"3","key":"4918_CR113","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3892\/ijo.2015.3101","volume":"47","author":"J Kim","year":"2015","unstructured":"Kim J, Han J, Jang Y et al (2015) High-capacity glycolytic and mitochondrial oxidative metabolisms mediate the growth ability of glioblastoma. Int J Oncol 47(3):1009\u20131016. https:\/\/doi.org\/10.3892\/ijo.2015.3101","journal-title":"Int J Oncol"},{"key":"4918_CR114","doi-asserted-by":"publisher","first-page":"117097","DOI":"10.1016\/j.bcp.2025.117097","volume":"240","author":"S Zhao","year":"2025","unstructured":"Zhao S, Cheng J, Zhou G et al (2025) Histone lactylation-driven YTHDF2 promotes non-small cell lung cancer cell glycolysis and stemness by recognizing m6A modification of SFRP2. Biochem Pharmacol 240:117097. https:\/\/doi.org\/10.1016\/j.bcp.2025.117097","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"4918_CR115","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1038\/s42255-024-01150-4","volume":"6","author":"W Xiao","year":"2024","unstructured":"Xiao W, Shrimali N, Vigder N et al (2024) Branched-chain \u03b1-ketoacids aerobically activate HIF1\u03b1 signalling in vascular cells. Nat Metab 6(11):2138\u20132156. https:\/\/doi.org\/10.1038\/s42255-024-01150-4","journal-title":"Nat Metab"},{"issue":"13","key":"4918_CR116","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1158\/1078-0432.CCR-13-0304","volume":"19","author":"WM Linehan","year":"2013","unstructured":"Linehan WM, Rouault TA (2013) Molecular pathways: Fumarate hydratase-deficient kidney cancer\u2013targeting the Warburg effect in cancer. Clin Cancer Res Off J Am Assoc Cancer Res 19(13):3345\u20133352. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0304","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04918-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-026-04918-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04918-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:05:02Z","timestamp":1787213102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-026-04918-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4918"],"URL":"https:\/\/doi.org\/10.1007\/s00280-026-04918-5","relation":{},"ISSN":["1432-0843"],"issn-type":[{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"<b>Competing interests<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"94"}}